CIK 0001377121 · Large accelerated filer
Protagonist Therapeutics, Inc
Sign in to watch- Ticker
- PTGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980505495
- Phone
- (510) 474-0170
- Business address
- 7707 GATEWAY BLVD., SUITE 140, NEWARK, CA, 94560-1160
- Former names
- Protagonist Therapeutics Inc, Protagonist Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $26,552,861
- in 2 filings, $26.6M under 10b5-1 plans
Net −$26,552,861. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-13 | PATEL DINESH V PH D President and CEO | Gift | −670 | 563,590 | ||
| 2025-06-10 | MOLINA ARTURO MD Chief Medical Officer | Option exercise | +10,000 | $8.04 | $80K | 93,892 |
| 2025-06-10 | MOLINA ARTURO MD Chief Medical Officer | Sale | −10,000 | $57.03 | $570K | 83,892 |
| 2025-06-10 | MOLINA ARTURO MD Chief Medical Officer | Option exercise · Stock Option (right to buy) | −10,000 | 75,971 | ||
| 2025-06-09 | MOLINA ARTURO MD Chief Medical Officer | Option exercise | +10,000 | $8.04 | $80K | 93,892 |
| 2025-06-09 | MOLINA ARTURO MD Chief Medical Officer | Sale | −10,000 | $55.51 | $555K | 83,892 |
| 2025-06-09 | MOLINA ARTURO MD Chief Medical Officer | Option exercise · Stock Option (right to buy) | −10,000 | 85,971 | ||
| 2025-04-28 | SELICK HAROLD E Director | Option exercise | +10,725 | $1.16 | $12K | 43,851 |
| 2025-04-28 | SELICK HAROLD E Director | Option exercise · Stock Option (right to buy) | −10,725 | 0 | ||
| 2025-04-22 | Ali Asif Chief Financial Officer | Sale | −1,756 | $46.00 | $81K | 61,065 |
| 2025-03-17 | Waddill William D. Director | Sale 10b5-1 | −4,000 | $54.25 | $217K | 13,130 |
| 2025-03-13 | MOLINA ARTURO MD Chief Medical Officer | Option exercise | +28,437 | $23.42 | $666K | 112,329 |
| 2025-03-13 | MOLINA ARTURO MD Chief Medical Officer | Option exercise | +2,077 | $38.98 | $81K | 114,406 |
| 2025-03-13 | MOLINA ARTURO MD Chief Medical Officer | Sale | −30,514 | $55.74 | $1.7M | 83,892 |
| 2025-03-13 | MOLINA ARTURO MD Chief Medical Officer | Option exercise · Stock Option (right to buy) | −28,437 | 69,063 | ||
| 2025-03-13 | MOLINA ARTURO MD Chief Medical Officer | Option exercise · Stock Option (right to buy) | −2,077 | 47,785 | ||
| 2025-03-12 | Ali Asif Chief Financial Officer | Option exercise | +15,203 | $12.17 | $185K | 78,024 |
| 2025-03-12 | Ali Asif Chief Financial Officer | Option exercise | +9,700 | $19.19 | $186K | 87,724 |
| 2025-03-12 | Ali Asif Chief Financial Officer | Sale | −24,903 | $58.73 | $1.5M | 62,821 |
| 2025-03-12 | Ali Asif Chief Financial Officer | Option exercise · Stock Option (right to buy) | −15,203 | 30,547 |
Page 8 of 29 · 580 trades